Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models

by Jinsong Hu, Els Van Valckenborgh, Eline Menu, Elke De Bruyne, Karin Vanderkerken
Published 2012-11-01

Metabolic Features of Multiple Myeloma

by Chaima El Arfani, Kim De Veirman, Ken Maes, Elke De Bruyne, Eline Menu
Published 2018-04-01

Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma

by Elke De Bruyne, Karin Vanderkerken, Ivan Van Riet, Ken Maes, Eline Menu, Els Van Valckenborgh
Published 2013-04-01

The Effects of Forodesine in Murine and Human Multiple Myeloma Cells

by Liesbeth Bieghs, Jo Caers, Elke De Bruyne, Els Van Valckenborgh, Fiona Higginbotham, Karin Vanderkerken, Eline Menu
Published 2010-01-01

The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma

by Philip Vlummens, Philip Vlummens, Kim De Veirman, Eline Menu, Elke De Bruyne, Fritz Offner, Karin Vanderkerken, Ken Maes
Published 2019-08-01

Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects

by Lien De Beck, Sarah Melhaoui, Kim De Veirman, Eline Menu, Elke De Bruyne, Karin Vanderkerken, Karine Breckpot, Ken Maes
Published 2018-10-01

The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response

by Eva De Smedt, Hui Lui, Hui Lui, Ken Maes, Kim De Veirman, Eline Menu, Karin Vanderkerken, Elke De Bruyne
Published 2018-12-01

AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma

by Siyang Yan, Niels Vandewalle, Nathan De Beule, Sylvia Faict, Ken Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Kim De Veirman
Published 2019-11-01

Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients.

by Liesbeth Bieghs, Malene Brohus, Ida B Kristensen, Niels Abildgaard, Martin Bøgsted, Hans E Johnsen, Cheryl A Conover, Elke De Bruyne, Karin Vanderkerken, Michael T Overgaard, Mette Nyegaard
Published 2016-01-01

Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma

by Kim De Veirman, Luigia Rao, Elke De Bruyne, Eline Menu, Els Van Valckenborgh, Ivan Van Riet, Maria Antonia Frassanito, Lucia Di Marzo, Angelo Vacca, Karin Vanderkerken
Published 2014-06-01

A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma

by Patrick Nylund, Alba Atienza Párraga, Jakob Haglöf, Elke De Bruyne, Eline Menu, Berta Garrido-Zabala, Anqi Ma, Jian Jin, Fredrik Öberg, Karin Vanderkerken, Antonia Kalushkova, Helena Jernberg-Wiklund
Published 2021-02-01

The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma

by Sylvia Faict, Inge Oudaert, Ludovic D’Auria, Jonas Dehairs, Ken Maes, Philip Vlummens, Kim De Veirman, Elke De Bruyne, Karel Fostier, Isabelle Vande Broek, Rik Schots, Karin Vanderkerken, Johannes V. Swinnen, Eline Menu
Published 2019-11-01

Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model.

by Haneen Nur, Karel Fostier, Sandrine Aspeslagh, Wim Renmans, Elisabeth Bertrand, Xavier Leleu, Mérédis Favreau, Karine Breckpot, Rik Schots, Marc De Waele, Els Van Valckenborgh, Elke De Bruyne, Thierry Facon, Dirk Elewaut, Karin Vanderkerken, Eline Menu
Published 2013-01-01